Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View up-to-date information on Krka dd Novo Mesto’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 19 Sep 2022 | Ningbo Krka Menovo Pharmaceutical Co Ltd Enters Phase I Clinical Trial Agreement with AXIS Clinicals Ltd for (hydrochlorothiazide + losartan potassium) (GDCT0466384) | Contract Service Agreement |
Ningbo Krka Menovo Pharmaceutical Co Ltd
Ningbo Krka Menovo Pharmaceutical Co Ltd
Ningbo Krka Menovo Pharmaceutical Co Ltd
|
AXIS Clinicals Ltd
AXIS Clinicals Ltd
AXIS Clinicals Ltd
|
| 13 Feb 2018 | Krka dd Novo Mesto Enters Phase IV Clinical Trial Agreement with Clinres farmacija doo for (amlodipine besylate + perindopril), (perindopril + indapamide + amlodipine) (GDCT0310543) | Contract Service Agreement |
Krka dd Novo Mesto
Krka dd Novo Mesto Krka dd Novo Mesto Krka dd Novo Mesto |
Clinres farmacija doo
Clinres farmacija doo
Clinres farmacija doo
Clinres farmacija doo
|
| 15 Nov 2017 | Ningbo Menovo Pharma and Krka dd Novo Mesto Enter into Agreement | Partnership | - |
Ningbo Menovo Pharmaceutical Co Ltd
Krka dd Novo Mesto |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer